Vinpocetine injection and production method thereof

A technology of vinpocetine and injection, applied in the field of pharmaceutical preparations, can solve the problems of aggravating the oxidation reaction rate, accelerating the degradation products, oxidative degradation, etc., and achieves inhibiting the degradation products of vinpocetine, ensuring sterility level, and good antioxidant performance. Effect

Active Publication Date: 2012-10-10
HENAN RUNHONG PHARMA
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] During the production and storage of Vinpocetine injection, it is easy to be oxidized and degraded, resulting in various degradation products. There are four main degradation products of Vinpocetine found so far, and excessive sterilization at 121°C will accelerate the appearance of degradation products.
Currently, the antioxidants often added to vinpocetine injections can effectively ensure that vinpocetine will not be degraded, but it is prone to oxidative degradation under high temperature sterilization con

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vinpocetine injection and production method thereof
  • Vinpocetine injection and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The Vinpocetine injection of the present embodiment consists of:

[0027] Vinpocetine 10g Ascorbic acid 0.3g

[0028] Sodium Metabisulfite 2g Tartaric Acid 6g

[0029] Sorbitol 160g Benzyl Alcohol 20g

[0030] Make injection 2000ml altogether.

[0031] The preparation method is as follows:

[0032] (1) 80% of the water for injection is filtered to remove oxygen, heated to 40°C, added ascorbic acid, tartaric acid and sodium metabisulfite, stirred to dissolve completely;

[0033] (2) Add Vinpocetine, stir, and dissolve completely;

[0034] (3) Add sorbitol, benzyl alcohol, stir and dissolve, make up water for injection, and use 0.3% activated carbon to stir and adsorb;

[0035] (4) Sterilize at a temperature of 121°C for 15 minutes, and fill with nitrogen.

Embodiment 2

[0037] The Vinpocetine injection of the present embodiment consists of:

[0038] Vinpocetine 12g Ascorbic Acid 0.1g

[0039] Sodium Metabisulfite 2g Tartaric Acid 8g

[0040] Sorbitol 160g Benzyl Alcohol 20g

[0041] Make injection 2000ml altogether.

[0042] The preparation method is as follows:

[0043] (1) 80% of the water for injection is filtered to remove oxygen, heated to 40°C, added ascorbic acid, tartaric acid and sodium metabisulfite, stirred to dissolve completely;

[0044] (2) Add Vinpocetine, stir, and dissolve completely;

[0045] (3) Add sorbitol, benzyl alcohol, stir and dissolve, make up water for injection, and use 0.3% activated carbon to stir and adsorb;

[0046] (4) Sterilize for 15 minutes at a temperature of 121°C, and fill with nitrogen.

Embodiment 3

[0048] The Vinpocetine injection of the present embodiment consists of:

[0049] Vinpocetine 20g Ascorbic Acid 0.45g

[0050] Sodium Metabisulfite 2g Tartaric Acid 15g

[0051] Sorbitol 160g Propylene Glycol 20g

[0052] Make injection 2000ml altogether.

[0053] The preparation method is as follows:

[0054] (1) 80% of the water for injection is filtered to remove oxygen, heated to 40°C, added ascorbic acid, tartaric acid and sodium metabisulfite, stirred to dissolve completely;

[0055] (2) Add Vinpocetine, stir, and dissolve completely;

[0056] (3) Add sorbitol, propylene glycol, stir and dissolve, make up water for injection, and use 0.3% activated carbon to stir and adsorb;

[0057] (4) Sterilize for 15 minutes at a temperature of 121°C, and fill with nitrogen.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a vinpocetine injection and a production method thereof. The vinpocetine injection comprises 10 to 20 parts of vinpocetine, 0.1 to 0.45 parts of ascorbic acid, 1 to 5 parts of one or more antioxidants, 6 to 15 parts of one or more cosolvents, 120 to 180 parts of one or more physical stabilizing agents, 15 to 25 parts of one or more vascular stimulation regulators and 2000 parts of water. Utilization of ascorbic acid in the above components is conducive to the dissolution of alkaline vinpocetine. A lot of experiments prove that the technical scheme of the invention is conducive to the dissolution of alkaline vinpocetine, realizes good antioxidation performances, and can effectively inhibit production of vinpocetine degradation products in production and storage processes.

Description

technical field [0001] The invention relates to a vinpocetine injection and a production method of the vinpocetine injection, belonging to the field of pharmaceutical preparations. Background technique [0002] Vinpocetine is an indole alkaloid with the chemical name ethyl(13as, 13bs)-13a-ethyl-2,3,5,6-13a,13b hexahydro-1H-indole[ 3,2,1-de]pyridine[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid. A large number of scientific studies have confirmed that: Many studies at home and abroad have found that Vinpocetine has a variety of pharmacological effects that are beneficial to the brain, cardiovascular, blood circulation and other systems. (1) Increase cerebral blood flow; (2) Promote the uptake and utilization of glucose and oxygen in the brain, increase ATP, and reduce the production of lactic acid during ischemia and hypoxia; (3) Prevent the excitotoxic death of brain cells (induced by excitatory amino acids Excessive receptor excitation); (4) reduce brain hypoxic damage a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K31/4375A61K47/26A61P9/00A61P25/00A61P9/10A61P39/06A61P9/08
Inventor 吴素林张炜靳勇
Owner HENAN RUNHONG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products